TY - JOUR
T1 - Thermal analysis of trace levels of polymorphic impurity in salmeterol xinafoate samples
AU - Tong, Henry H.Y.
AU - Shekunov, Boris Yu
AU - York, Peter
AU - Chow, Albert H.L.
N1 - Funding Information:
This study was supported in part by financial support from the Research Grant Council of Hong Kong (Earmarked Grant CHHK4244/98M).
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Purpose. To quantify trace levels of polymorphic impurity in two salmeterol xinafoate (SX) Form I samples: granular SX (GSX) produced by fast-cooling crystallization and micronized SX (MSX) prepared from GSX by micronization. Methods. SX-I and SX-II produced by solution enhanced dispersion by supercritical fluids (SEDS™) were the reference polymorphs (100% pure) used for quantitative comparison. The percentage of polymorphic conversion, α, of each Form I sample to Form II was measured by differential scanning calorimetry (DSC) as a function of time (i.e., at different scanning speeds). The data were analyzed by the Avrami-Erofe'ev (AE) equation using an iterative fitting computer program. SX-I samples containing 1.24, 4.41, and 13.47% (w/w) of SX-II as physical mixtures were subjected to similar analysis and data treatment. A mathematical relationship based on an instantaneous nucleation model was derived to relate the AE rate constants, k, of pure SX-I and physical mixtures to weight percentage of SX-II. This relationship was then used to calculate the percentage polymorphic impurity of GSX and MSX from their k values. For relative comparison of the Form-II nuclei present, the k values of SX-I, GSX, and MSX were used to calculate their differences in free energy of nucleation. Results. The AE equation affords good (r2 ≈ 0.81) to excellent (r2 ≈ 0.99) fits of data for the samples. The levels of polymorphic impurity in GSX and MSX are 0.16 and 0.62% (w/w), respectively. Based on the free energy differences of nucleation between the reference SX-I material and the other samples, the number (and size) of the Form II nuclei present in the samples rank in the order: MSX > GSX > SX-I. Conclusions. DSC is a useful tool for assessing the polymorphic purity of SX materials and possibly other enantiotropic pairs showing similar thermal behavior.
AB - Purpose. To quantify trace levels of polymorphic impurity in two salmeterol xinafoate (SX) Form I samples: granular SX (GSX) produced by fast-cooling crystallization and micronized SX (MSX) prepared from GSX by micronization. Methods. SX-I and SX-II produced by solution enhanced dispersion by supercritical fluids (SEDS™) were the reference polymorphs (100% pure) used for quantitative comparison. The percentage of polymorphic conversion, α, of each Form I sample to Form II was measured by differential scanning calorimetry (DSC) as a function of time (i.e., at different scanning speeds). The data were analyzed by the Avrami-Erofe'ev (AE) equation using an iterative fitting computer program. SX-I samples containing 1.24, 4.41, and 13.47% (w/w) of SX-II as physical mixtures were subjected to similar analysis and data treatment. A mathematical relationship based on an instantaneous nucleation model was derived to relate the AE rate constants, k, of pure SX-I and physical mixtures to weight percentage of SX-II. This relationship was then used to calculate the percentage polymorphic impurity of GSX and MSX from their k values. For relative comparison of the Form-II nuclei present, the k values of SX-I, GSX, and MSX were used to calculate their differences in free energy of nucleation. Results. The AE equation affords good (r2 ≈ 0.81) to excellent (r2 ≈ 0.99) fits of data for the samples. The levels of polymorphic impurity in GSX and MSX are 0.16 and 0.62% (w/w), respectively. Based on the free energy differences of nucleation between the reference SX-I material and the other samples, the number (and size) of the Form II nuclei present in the samples rank in the order: MSX > GSX > SX-I. Conclusions. DSC is a useful tool for assessing the polymorphic purity of SX materials and possibly other enantiotropic pairs showing similar thermal behavior.
KW - Nucleation model
KW - Polymorphic impurity determination
KW - Salmeterol xinafoate
KW - Thermal analysis
UR - http://www.scopus.com/inward/record.url?scp=0141567431&partnerID=8YFLogxK
U2 - 10.1023/A:1025758127358
DO - 10.1023/A:1025758127358
M3 - Article
C2 - 14567637
AN - SCOPUS:0141567431
SN - 0724-8741
VL - 20
SP - 1423
EP - 1429
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 9
ER -